Latisse is the brand name for bimatoprost when used to treatment eyelash or eyebrow hypotrichosis, a term used to describe inadequate or slow hair growth. It is only available in America. Bimatoprost was originally used as an eyedrop to treat glaucoma, but clinicians noticed that it had the interesting side effect of eyelash growth. Applying Latisse to the base of the eyelash results in eyelashes that are longer, thicker and darker than natural.
The Latisse is packed with disposable applicators and the treatment itself comes as a solution within a smaller dropper bottle, much like Optrex. Allergan manufactures the treatment which gained United States Federal Drugs Association (FDA) approval in December 2008.
To gain FDA approval the treatment had to be studied for its safety and efficacy as a cosmetic medication. It was found to be safe and effective at growing eyelashes and subsequently eyebrows. The average result was a 25% increase in length, 106% increase in thickness and 18% darker lashes.
Mylash was originally founded by Tom Walker in 2007 based on his knowledge that a well studied treatment for glaucoma, an eye condition, had an interesting side effect – eyelash growth!
He has a keen interest in hair growth and non-surgical ways to improve this for cosmetic purposes and post-chemotherapy.
Dr Walker has been published in the Journal of Plastic and Reconstructive Surgery and has contributed his professional opinions to articles in Hello magazine, Elle, Grazia and many more.
Mylash continues to only use British based medical doctors to ensure a safe service that offers you clinically proven treatments.
Read testimonials from some of our celebrity clients and leading journalists.
Our service has been featured in articles in many major press publications.
Read articles on the science behind the treatment and the latest developments.